Treatment_of_pulmonary_endometriosis_with_a_long-acting_GnRH_agonist._We_report_the_case_of_a_patient_who_was_successfully_treated_with_a_long-acting_GnRH_agonist_for_pulmonary_endometriosis._This_28-year-old_woman_had_symptomatic_pleural_endometriosis,_documented_by_biopsies,_as_well_as_symptomatic_pelvic_endometriosis._Two_surgical_procedures,_consisting_of_excision_of_pleural_endometriotic_tissue_and_partial_pleurectomies,_failed_to_relieve_her_chest_symptoms._Little_relief_was_achieved_with_pseudopregnancy_treatment._Satisfactory_symptomatic_improvement_was_obtained_with_danazol,_but_this_medication_had_to_be_discontinued_because_of_severe_side_effects._Trial_of_a_GnRH_agonist,_leuprolide_acetate,_achieved_complete_remission_of_her_chest_symptoms;_in_addition,_the_patient_became_pregnant_immediately_after_cessation_of_therapy._Gonadotropin-releasing_hormone_agonist_therapy_may_be_an_important_therapeutic_alternative_for_women_with_pulmonary_endometriosis_who_cannot_tolerate_danazol_treatment_and_in_whom_surgical_therapy_fails_to_relieve_the_chest_symptoms.